Introduction Executive Summary Chronic lymphocytic leukemia: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Late Stage Products (Phase III) • Comparative Analysis Ublituximab: TG Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis Cirmtuzumab: Oncternal Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early stage products (Phase I) • Comparative Analysis NX-2127: Nurix • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Chronic lymphocytic leukemia Key Companies Chronic lymphocytic leukemia Key Products Chronic lymphocytic leukemia- Unmet Needs Chronic lymphocytic leukemia- Market Drivers and Barriers Chronic lymphocytic leukemia- Future Perspectives and Conclusion Chronic lymphocytic leukemia Analyst Views Chronic lymphocytic leukemia Key Companies Appendix

Table 1 Total Products for Chronic lymphocytic leukemia Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Octapharma • Celgene • Loxo Oncology • Janssen Research & Development, LLC • TG therapeutics • AFA Insurance • MorphoSys AG • Bristol Myers Squibb • IO Biotech • Astex Pharmaceuticals • Novartis • Oncternal Therapeutics • Cellectar Biosciences, Inc. • Zhejiang DTRM Biopharma • Incyte Corporation • Millennium Pharmaceuticals, Inc. • NOXXON Pharma • Merck Sharp & Dohme Corp • Genentech, Inc. • Rhizen Pharmaceuticals • Gilead Sciences/Ono Pharmaceutical • BioInvent International AB • Chongqing Precision Biotech Co., Ltd • Mustang Bio • Genmab • Genor Biopharma Co., Ltd. • Iovance Biotherapeutics • Juno therapeutics • Lava Therapeutics • Miltenyi Biomedicine GmbH • Ascentage Pharma • Aprea Therapeutics • BeiGene • Acerta Pharma BV • Telios Pharma, Inc. • NovalGen Ltd. • Nurix